# 64-x

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/64-x

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.64xbio.com
- Total disclosed funding: $55M
- Latest round: Series A (Jan 19, 2022)
- Investors on record: 9

## About

Founded in 2017 and based in California, US, 64-x, Inc. trading under the name 64x Bio operates as a biotechnology company that utilizes genome engineering and screening technologies to manufactures cell and gene therapeutics. Alexis Rovner is the co-founder and CEO of the company. In January 2022, 64-x, Inc. raised USD 55 million in Series A funding led by LifeForce Capital including Alix Ventures LP, First Round Capital, Future Ventures, Northpond Ventures, and other individual investors.

The company provides a vectorselect™ platform that leverages DNA library synthesis, next-generation sequencing, and computational approaches to dramatically increase experimental throughput and enable the discovery of cell lines with radically improved productivities. The firm's platform technology enables pharmaceutical and biotechnology companies to bring cell and gene therapies to patients more effectively, providing purpose-built genetically engineered cell lines that increase the efficiency of viral vector production, improve manufacturing capacity and reduce manufacturing costs. 

The organization plans to use the January 2022 financing for the expansion of its vectorselect platform and also grow its employee base and partnership efforts with gene therapy companies, through the expansion of additional intellectual property, operations, and business development infrastructure.

## Funding rounds

- Series A, Jan 19, 2022, $55M — First Round Capital, SV Angel, BoxGroup, Refactor Capital, Future Ventures, LifeForce Capital, Fifty Years, Northpond Ventures, Alix Ventures

## Investors

- First Round Capital (https://capitalatlas.ai/funds/first-round-capital) — Series A
- SV Angel (https://capitalatlas.ai/funds/sv-angel) — Series A
- BoxGroup (https://capitalatlas.ai/funds/boxgroup) — Series A
- Refactor Capital (https://capitalatlas.ai/funds/refactor-capital) — Series A
- Future Ventures — Series A
- LifeForce Capital (https://capitalatlas.ai/funds/lifeforce-capital) — Series A
- Fifty Years (https://capitalatlas.ai/funds/fifty-years) — Series A
- Northpond Ventures (https://capitalatlas.ai/funds/northpond-ventures) — Series A
- Alix Ventures (https://capitalatlas.ai/funds/alix-ventures) — Series A